文献速递神经免疫

视神经脊髓炎谱系疾病中脑脊液抗AQP4与抗MOG抗体来源差异

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
PubMed 文献 · Neurology · 2021-05-12

研究比较38例MOG-IgG相关疾病与36例AQP4-IgG阳性NMOSD患者急性期血清和脑脊液抗体滴度,发现MOG-IgG更常出现脑脊液局限阳性及鞘内合成,而AQP4-IgG罕见。MOG-IgG商值显著高于AQP4-IgG,且抗体指数升高更常见,提示两者B细胞转运和抗体产生特性不同。

要点

  • MOG-IgG可仅脑脊液阳性,AQP4-IgG无此现象
  • MOG-IgG鞘内合成频率高于AQP4-IgG
  • MOG-IgG脑脊液滴度与细胞数相关,与残疾无关

核心结论

  • MOG-IgG的鞘内产生可能比AQP4-IgG更频繁,提示两种疾病B细胞转运和抗体产生特性不同。

研究设计与样本

  • 研究纳入38例MOG-IgG相关疾病和36例AQP4-IgG阳性NMOSD患者,急性期同时采集血清和脑脊液,计算白蛋白、总IgG及特异性抗体的商值和抗体指数。

主要发现

  • 血脑屏障破坏表现为白蛋白商值升高,见于75.0%的MOG-IgG阳性病例和43.8%的AQP4-IgG阳性病例。
  • MOG-IgG商值超过AQP4-IgG商值10倍以上(效应量r=0.659,p<0.0001)。
  • 抗体指数>4.0在21例MOG-IgG中12例确认,而16例AQP4-IgG中仅1例(φ=0.528,p<0.0001)。
  • 脑脊液MOG-IgG滴度(ρ=0.519,p=0.001)和MOG-IgG抗体指数(ρ=0.472,p=0.036)与脑脊液细胞数相关,但与临床残疾无关。

临床怎么用

  • 对于疑似MOG-IgG相关疾病患者,即使血清抗体阴性,也应考虑检测脑脊液MOG-IgG。
  • 脑脊液MOG-IgG滴度和抗体指数升高提示鞘内合成,可能反映疾病活动性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate the differences in the source and in the level of intrathecal synthesis between anti-aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibodies (MOG-IgG). METHODS: Thirty-eight patients with MOG-IgG-associated disease and 36 with AQP4-IgG-positive neuromyelitis optica spectrum disorders (NMOSD) were studied for the antibody titers in the sera and CSF simultaneously collected in the acute attacks. The quotients between CSF and serum levels of albumin, total immunoglobulin G, and each disease-specific antibody were calculated. Intrathecal production level in each disease-specific antibody was evaluated by calculating the antibody index from these quotients. RESULTS: Eleven of the 38 patients with MOG-IgG were positive for the antibody only in the CSF, while no patient with AQP4-IgG showed CSF-restricted AQP4-IgG. Blood-brain barrier compromise as shown by raised albumin quotients was seen in 75.0% of MOG-IgG-positive cases and 43.8% of AQP4-IgG-positive cases. Moreover, MOG-IgG quotients were >10 times higher than AQP4-IgG quotients (effect size r = 0.659, p < 0.0001). Elevated antibody index (>4.0) was confirmed in 12 of 21 with MOG-IgG, whereas it was seen only in 1 of 16 with AQP4-IgG (φ = 0.528, p < 0.0001). The CSF MOG-IgG titers (ρ = 0.519, p = 0.001) and antibody indexes for MOG-IgG (ρ = 0.472, p = 0.036) correlated with the CSF cell counts but not with clinical disability. CONCLUSIONS: Intrathecal production of MOG-IgG may occur more frequently than that of AQP4-IgG. This finding implies the different properties of B-cell trafficking and antibody production between MOG-IgG-associated disease and AQP4-IgG-positive NMOSD.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Akaishi T, Takahashi T, Misu T, et al. Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder. Neurology. 2021. PMID: 33980704. doi:10.1212/WNL.0000000000012175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。